Interestingly, we detected a significant increase in IRF5 expression within SLE CD4+ T cells as compared to non-genotyped healthy controls, and this difference was conserved between homozygous risk and non-risk donors [17,26,27] (Figure 1C). The gene discussed is CD4; the disease is systemic lupus erythematosus.